Michael Cherny analyst LEERINK

Currently out of the existing stock ratings of Michael Cherny, 158 are a BUY (56.03%), 92 are a HOLD (32.62%), 32 are a SELL (11.35%).

Michael Cherny

Work Performance Price Targets & Ratings Chart

Analyst Michael Cherny, currently employed at LEERINK, carries an average stock price target met ratio of 61.86% that have a potential upside of 24.14% achieved within 219 days. Previously, Michael Cherny worked at UBS, EVERCORE, BAML.

Michael Cherny’s has documented 545 price targets and ratings displayed on 39 stocks. The coverage is on Healthcare, Financial Services, Consumer Defensive, Consumer Cyclical sectors.

Most recent stock forecast was given on DOCS, Doximity at 29-Jun-2026.

Wall Street Analyst Michael Cherny

Analyst best performing recommendations are on OMI (OWENS & MINOR).
The best stock recommendation documented was for OMI (OWENS & MINOR) at 8/11/2025. The price target of $5 was fulfilled within 1 day with a profit of $0.37 (7.99%) receiving and performance score of 79.91.

Average potential price target upside

ABC AmerisourceBergen ACCD Accolade  CAH Cardinal Health CERN Cerner Corp CNVY Convey Holding Parent CVS CVS Health Corp GOCO GoHealth HSIC Henry Schein MCK McKesson NVST Envista Holdings Corp OMI Owens & Minor PDCO Patterson Companies PGNY Progyny RCM R1 RCM SGFY Signify Health TDOC Teladoc WBA Walgreens Boots Alliance PINC Premier ATHN athenahealth XRAY Dentsply Sirona HIMS Hims Hers Health SONX Sonendo MDRX Allscripts Healthcare Solutions TRHC Tabula Rasa HealthCare GDRX Goodrx Holdings  ALGN Align Technology COR Cencora DGX Quest Diagnostics ICLR ICON PLC IQV IQVIA Holdings LH Laboratory of America Holdings BOLD Audentes Therapeutics NXGN Nextgen Healthcare CERT Certara MEDP Medpace Holdings CHNG Change Healthcare DOCS Doximity OM Outset Medical  SON Sonoco Products Company

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Feb-2018

$215

$40.04 (22.89%)

$187

2 years 11 months ago
(07-Aug-2023)

15/16 (93.75%)

$28.91 (15.54%)

636

Hold Since 27-May-2022

$190

$15.04 (8.60%)

$176

2 years 11 months 4 days ago
(03-Aug-2023)

12/12 (100%)

$-0.86 (-0.45%)

392

Buy Since 11-Oct-2022

$215

$40.04 (22.89%)

$200

2 years 11 months 4 days ago
(03-Aug-2023)

7/10 (70%)

$24.14 (12.65%)

211

Buy Since 05-Aug-2021

$220

$45.04 (25.74%)

$213

2 years 11 months 4 days ago
(03-Aug-2023)

11/17 (64.71%)

$29.14 (15.27%)

326

$190

$15.04 (8.60%)

2 years 11 months 4 days ago
(03-Aug-2023)

9/9 (100%)

$-0.86 (-0.45%)

440

Show more analysts

Please expand the browser size to see the chart

Which stock is Michael Cherny is most bullish on?

Potential upside of $213.7 has been obtained for MCK (MCKESSON)

Which stock is Michael Cherny is most reserved on?

Potential downside of -$72.6 has been obtained for MEDP (MEDPACE HOLDINGS)

What Year was the first public recommendation made by Michael Cherny?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?